CTRI/2022/03/041364尚未招募4 期
Study Of Efficacy And Safety Of Oral Minoxidil(2.5MG) V/S Oral Finasteride (1MG) in Male Androgenic Alopecia-A Double Blind Study
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 28
- 试验地点
- 1
- 主要终点
- 1.average hair thickness improvement by more than 10 percent
研究概览
简要总结
Topical minoxidil is FDA approved treatment for androgenic alopecia but oral minoxidil is being used and its efficacy is being tested in many studies but no study is being done to compare the efficacy between oral finasteride and oral minoxidil.Therefore comparative study between oral minoxidil and oral finasteride will resulting in establishing a more effective drug in treatment of androgenic alopecia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Participant, Investigator and Outcome Assessor Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 50.00 Year(s)（—）
- 性别
- Male
入选标准
- •Male patient comes with history or clinical findings suggestive of androgenic alopecia.
- •Age group more than 18 years of age and less than 50 years of age
- •Hamilton grade 2-6
- •Have given written consent before investigation and starting the drug.
排除标准
- •Patient who is hypotensive or hypertensive
- •Patients with grade 1 or grade 7 alopecia.
- •Patient with cardiac diseases (including angina, coronary artery disease, recent or acute myocardial infarction, pericardial effusion)
- •Patients with cerebrovascular diseases
- •Patients with deranged liver and kidney function.
- •Patients allergic to finasteride or minoxidil.
- •Patient on any treatment for androgenic alopecia for last 2 months.
结局指标
主要结局
1.average hair thickness improvement by more than 10 percent
时间窗: Baseline | 4 weeks | 8 weeks | 12 weeks | 16 weeks | 20 weeks | 24 weeks
2.Increase in terminal vellus hair ratio.
时间窗: Baseline | 4 weeks | 8 weeks | 12 weeks | 16 weeks | 20 weeks | 24 weeks
次要结局
- clinical photography(Baseline)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
4 期
A Clinical Trial To Study the Effects and Safety Of Two Drugs Minoxidil and Finasteride in Male Androgenic AlopeciaCTRI/2022/03/041364Krishna institute of medical sciences
Unknown
1 期
Efficacy and Safety Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Androgenetic AlopeciaObjective (Goal)Self-AssessmentAdverse EffectsNCT01650272Siriraj Hospital20
已完成
不适用
Topical treatment regimens in male androgenetic alopeciaCTRI/2020/05/025390Lady Hardinge Medical College60
尚未招募
不适用
Low Dose Oral Minoxdil in Androgenic AlopeciaNCT07018349Jinnah Postgraduate Medical Centre76
招募中
2 期
To compare the efficacy and safety profile of topical minoxidil versus low dose oral minoxidil in patients with hairfall and hair thinning due to androgenetic alopecia in tertiary care teaching hospital,Haldwani,Uttarakhand.CTRI/2024/03/063477Dr Sally Rajkumari80